Session 1

Title

Overcoming Key Challenges in Vaccine Development

Watch Now

Cytiva's Biopharma Resilience Index measured the ability of different nations to meet their domestic biotherapeutic needs. The Index revealed that biomanufacturing agility is a critical element to establishing this resilience and we've witnessed this during COVID-19 vaccines. We have learned from COVID-19 vaccine development that the time to develop and manufacture a vaccine is paramount to saving lives. In addition, variants may arise which further underpins the criticality of vaccine responsiveness speed. Thus, the ideal platform for vaccine development should be fast, versatile, in terms of applicable to different disease and variant target antigens, and easy to scale manufacturing either centrally to mazimize efficiencies or e locally to minimize logistical issue in the distribution of a vaccine. In this presentation.

Session 2

Title

What to Look for in a CDMO Selection, and How to Stand Out in the Race.

Watch Now

The business concept of a Custom Development and Manufacturing Organization (CDMO) is mainly to provide expertise and resources in a fee-for-service relationship during the development and supply of a biopharmaceutical.
This is a way for large Pharma and Biotechs to outsource development peaks, and limit the CAPEX and human costs. In this lecture, Bryan will go through the main areas of interest when a pharmaceutical company evaluates a CDMO. Whether you are in a position to outsource part of your production to a CDMO, or if you want to stand out in this race, this webinar should raise your interest.

Title

Regulatory Inspections and the post-COVID-19 restart, are you ready?

Watch Now

Title

Ensuring compliance and efficiency through starlims scientific data management system

Watch Now

More than ever, laboratories need solutions to help them efficiently capture and parse documents and data, reducing the tedious, time consuming and error-prone manual data entry. For organizations considering a digital transformation strategy, the Scientific Data Management System (SDMS) can be a key element when it comes to moving away from paper-based documents while keeping data integrity.

Title

How to Increase Productivity and Efficiency in Pharmaceutical Quality Control Labs

Watch Now

Delays in product release can lead to a build-up of inventory and impact the time to market. On top of these, ensuring regulatory compliance while maintaining robust process requirements with repeatability of results are common daily challenges faced by pharma quality control labs, and these can require significant valuable resources.